Matches in Wikidata for { <http://www.wikidata.org/entity/Q61821600> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q61821600 description "artículu científicu" @default.
- Q61821600 description "im April 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61821600 description "wetenschappelijk artikel" @default.
- Q61821600 description "наукова стаття, опублікована у квітні 2012" @default.
- Q61821600 name "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM" @default.
- Q61821600 name "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM(4-HPR/LXS) oral powder in combination with ketoconazole and vincristine against recurrent neuroblastoma xenografts" @default.
- Q61821600 type Item @default.
- Q61821600 label "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM" @default.
- Q61821600 label "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM(4-HPR/LXS) oral powder in combination with ketoconazole and vincristine against recurrent neuroblastoma xenografts" @default.
- Q61821600 prefLabel "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM" @default.
- Q61821600 prefLabel "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM(4-HPR/LXS) oral powder in combination with ketoconazole and vincristine against recurrent neuroblastoma xenografts" @default.
- Q61821600 P1433 Q61821600-BDE14DF0-FE7C-4883-A720-556C7D8B8BA2 @default.
- Q61821600 P1476 Q61821600-D94B217C-44EA-4C0C-BAE6-D34AC1D80A6E @default.
- Q61821600 P2093 Q61821600-235D7FDA-586D-4E9C-8ABB-CAB082D45018 @default.
- Q61821600 P2093 Q61821600-471AD7A6-3C9B-4A1C-9AD2-064D9E9BB957 @default.
- Q61821600 P2093 Q61821600-8ABBC1B7-9777-438F-BF31-D2EBBD4C9CED @default.
- Q61821600 P2093 Q61821600-DBC7D256-6305-4D71-9691-56F912B09E07 @default.
- Q61821600 P304 Q61821600-FC277F7F-8858-47AE-B560-69103B3ED962 @default.
- Q61821600 P31 Q61821600-4F8D3765-F456-4BCE-9636-D358351E31EF @default.
- Q61821600 P356 Q61821600-9158C6C8-9856-45C6-9197-D13162FDCEA6 @default.
- Q61821600 P407 Q61821600-133B5230-EE86-4C0A-99CE-5B37DDFF17FE @default.
- Q61821600 P433 Q61821600-96AFC64C-2E42-4519-8A4B-FEE8976D1B4F @default.
- Q61821600 P478 Q61821600-50171FE5-CC79-41C4-9FA3-4515DA9F3D8E @default.
- Q61821600 P577 Q61821600-8ECF5953-2AD6-4617-8647-F01834CEB3B1 @default.
- Q61821600 P921 Q61821600-385A1E4C-6996-45C7-8ED0-F50550F44FA1 @default.
- Q61821600 P921 Q61821600-617A79E7-C168-4764-9F77-DCB428906E76 @default.
- Q61821600 P356 1538-7445.AM2012-2493 @default.
- Q61821600 P1433 Q326097 @default.
- Q61821600 P1476 "Abstract 2493: Enhanced activity of fenretinide/-LYM-X-SORBTM(4-HPR/LXS) oral powder in combination with ketoconazole and vincristine against recurrent neuroblastoma xenografts" @default.
- Q61821600 P2093 "Barry J. Maurer" @default.
- Q61821600 P2093 "C. Patrick Reynolds" @default.
- Q61821600 P2093 "Lluis Lopez-Barcons" @default.
- Q61821600 P2093 "Min H. Kang" @default.
- Q61821600 P304 "2493-2493" @default.
- Q61821600 P31 Q13442814 @default.
- Q61821600 P356 "10.1158/1538-7445.AM2012-2493" @default.
- Q61821600 P407 Q1860 @default.
- Q61821600 P433 "8 Supplement" @default.
- Q61821600 P478 "72" @default.
- Q61821600 P577 "2012-04-15T00:00:00Z" @default.
- Q61821600 P921 Q64148587 @default.
- Q61821600 P921 Q938205 @default.